期刊文献+

小剂量肠溶阿司匹林干预缺血性卒中对慢性胃炎患者胃黏膜损伤的风险性对照研究 被引量:5

下载PDF
导出
摘要 目的观察长期服用小剂量肠溶阿司匹林干预缺血性卒中对慢性胃炎患者胃黏膜损伤的情况。方法随机把长期服用小剂量肠溶阿司匹林的慢性胃炎患者650例分为研究组和对照组,在常规治疗基础上,研究组给予肠溶阿司匹林75~100mg,1次/d;对照组给予维生素E100mg,1次/d,连续随访3年,观察上消化道出血和胃炎症状活动情况,有上消化道出血和胃炎症状活动的患者进行胃镜复查。结果研究组和对照组上消化道出血发病率分别为3.4%和2.8%,胃炎症状活动发生率分别13.1%和15.8%,2组比较均无显著性差异(P〉0.05),2组胃镜复查显示胃黏膜病损程度基本相似。结论慢性胃炎患者长期服用小剂量肠溶阿司匹林对胃黏膜损伤的风险性不增加,可以常规应用小剂量肠溶阿司匹林干预缺血性卒中。
出处 《中国实用神经疾病杂志》 2009年第17期28-29,共2页 Chinese Journal of Practical Nervous Diseases
  • 相关文献

参考文献8

二级参考文献40

  • 1Fujimura Y, Titani K, Holland LZ. von Willebrand factor. A reduced and alkylated 52/48-kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein Ib. J Biol Chem, 1986, 261 : 381 - 385.
  • 2Fuster V, Jang IK. Role of platelet-inhibitor agents in coronary artery disease. In: Topoi EJ, ed. Textbook of Interventional Cardiology. 2nd ed. Vol. 1. Philadelphia: W B Saunders, 1994.3 -22.
  • 3FitzGerald GA, Oates JA, Hawiger J, et al. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest, 1983, 71:676 -688.
  • 4Patrono C, Coller B, Dalen JE, et al. Platelet-active drugs : the relationships among dose, effectiveness, and side effects. Chest, 2001,119(1 Suppl): 39S - 63 S.
  • 5Meyers KM, Holmsen H, Seachord CL. Comparative study of platelet dense granule constituents. Am J Physiol, 1982, 243:R454 -R461.
  • 6Solet DJ, Zacharski LR, Plehn JF. The role of adenosine 5'-diphosphate receptor blockade in patents with cardiovascular disease. Am J Med, 2001, 111:45 -53.
  • 7Manns JM, Brenna KJ, Colman RW, et al. Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosohodiesterases. Thromb Haemost, 2002, 87:873 -879.
  • 8FitzGerald GA. Dipyridamole. N Engl J Med, 1987, 316:1247 -1257.
  • 9Phillips DR, Charo IF, Scarborough RM. GPIIb-IIIa: the responsive integrin. Cell, 1991, 65:359 -362.
  • 10Mousa SA, Kapil R, Mu DX. Intravenous and oral antkhrombotic efficacy of the novel platelet GPIIb/IIIa antagonist roxifiban(DMP754) and its free acid form, XV459. Arterioscler Thromb Vasc Biol, 1999, 19:2535-2541.

共引文献53

同被引文献60

引证文献5

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部